Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

YAP1, a key mediator of the Hippo pathway, plays an important role in tumorigenesis. Alternative splicing of human YAP1 mRNA results in two major isoforms: YAP1-1, which contains a single WW domain, and YAP1-2, which contains two WW domains, respectively. We here investigated the functions and the underlying regulatory mechanisms of the two YAP1 isoforms in the context of EGF-induced epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC). Human NSCLC cell lines express both YAP1-1 and YAP1-2 isoforms-although when compared to YAP1-1, YAP1-2 mRNA levels are higher while its protein expression levels are lower. EGF treatment significantly promoted YAP1 expression as well as EMT process in NSCLCs, whereas EGF-induced EMT phenotype was significantly alleviated upon YAP1 knockdown. Under normal culture condition, YAP1-1 stable expression cells exhibited a stronger migration ability than YAP1-2 expressing cells. However, upon EGF treatment, YAP1-2 stable cells showed more robust migration than YAP1-1 expressing cells. The protein stability and nuclear localization of YAP1-2 were preferentially enhanced with EGF treatment. Moreover, EGF-induced EMT and YAP1-2 activity were suppressed by inhibitor of AKT. Our results suggest that YAP1-2 is the main isoform that is functionally relevant in promoting EGF-induced EMT and ultimately NSCLC progression. © 2022 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Citation

Qiang Guo, Mei-Yu Quan, Le Xu, Yaxin Cai, Jue-Ting Cai, Xue Li, Guifeng Feng, Aiping Chen, Weiwei Yang, Qhaweni Dhlamini, Tian-Fang Jiang, Chengguo Shen, Chengshui Chen, Jin-San Zhang. Enhanced nuclear localization of YAP1-2 contributes to EGF-induced EMT in NSCLC. Journal of cellular and molecular medicine. 2022 Feb;26(4):1013-1023

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 35014181

View Full Text